Computer model helps tailor transplant meds for kids
NCT ID NCT06095895
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a computer model can help doctors give the right dose of anti-rejection drugs to children after a kidney transplant. The model used drug levels from blood samples to predict future exposure and guide dosing. 29 children participated, and the goal was to see how accurate the model's predictions were.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AREA UNDER CURVE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Radboudumc
Nijmegen, Gelderland, 6500HB, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a natural antibody quiet inflammation? a new trial investigates
- Can a simple calcium tablet help prevent postpartum bleeding?
- First human trial launches for Hemay5259: a new Extended-Release drug candidate
- Apples' hidden power: study probes how polyphenols scavenge harmful carbonyls
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- New painkiller injection could cut opioid use after chest surgery